ICN Pharmaceuticals confirmed earlier reports that it...
- Share via
ICN Pharmaceuticals confirmed earlier reports that it is considering acquiring up to 25% of a West German pharmaceutical firm, Schering AG. The Costa Mesa company said in a statement that the move was part of a 3-year effort to expand its marketing capabilities.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
